Tinnitus treatment is often filled with conflicting claims, making it difficult to know what is actually supported by evidence. In this episode, Dr. Layne Garrett breaks down Lenire, an FDA-approved bimodal neuromodulation device, and explains what both clinical trials and real-world data reveal about its effectiveness.

You will learn how Lenire works by combining sound stimulation with mild tongue stimulation to drive targeted neuroplastic changes in the brain. We review the TENT-A3 clinical trial that led to FDA approval and then examine three independent real-world studies from U.S. clinics that show consistent outcomes across different patient populations.

This episode also explains how tinnitus improvement is measured using THI and TFI, why candidacy matters, and how Lenire fits into a comprehensive treatment plan rather than acting as a standalone solution. Patients struggling with moderate to severe tinnitus, especially those not finding relief with hearing aids alone, may benefit most from this approach.

Dr. Garrett brings over two decades of experience in tinnitus care, including REM-verified hearing aid fittings and evidence-based treatment strategies, helping patients make informed and confident decisions about their care.

You can learn more here.

Visit our Free Online Learning Center to read more about hearing loss and tinnitus.

If you are in Northern Utah and would like to schedule an appointment click here.